This brand name is authorized in Mexico
The drug BROGAMAX contains a combination of these active pharmaceutical ingredients (APIs):
1
Ambroxol
UNII CC995ZMV90 - AMBROXOL HYDROCHLORIDE
|
Ambroxol induces activation of the surfactant system by acting directly on the type II pneumocytes of the alveoles and the Clara cells in the region of the small airways. It promotes the formation and outward transfer of surface-active material in the alveolar and bronchial region of the foetal and adult lungs. |
2
Sulfamethoxazole
UNII JE42381TNV - SULFAMETHOXAZOLE
|
Sulfamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis. |
3
Trimethoprim
UNII AN164J8Y0X - TRIMETHOPRIM
|
Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: MX | Comisiรณn Federal para la Protecciรณn contra Riesgos Sanitarios | Identifier(s): 010M2004, 401M2004 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.